Search clinical trials for: Cyclophosphamide (CTX)

Total 5002 results

University of Michigan

Withdrawn

Customized Titanium Membrane for Growing Jaw Bone Horizontally

Bone Gain

United States
Eliem Therapeutics (UK) Ltd.

Completed

Efficacy and Safety of ETX-018810 in Subjects With Lumbosacral Radicular Pain

Lumbosacral Radiculopathy

United States
Eliem Therapeutics (UK) Ltd.

Completed

Efficacy and Safety of ETX-018810 for the Treatment of Diabetic Peripheral Neuropathic Pain

Diabetic Peripheral Neuropathic Pain | Diabetic Peripheral Neuropathy

United States
Ureca BV

Terminated

Safety and Efficacy of the URECA CTO Device

Peripheral Vascular Disease

Netherlands
Amicus Therapeutics

Active, not recruiting

Long-Term Follow Up of CLN6 Batten Disease Subjects Following Gene Transfer

Batten Disease | CLN6

United States
Larimar Therapeutics, Inc.
Veristat, Inc.; Metrum Research Group, LLC

Completed

Multiple Ascending Dose Study of CTI-1601 Versus Placebo in Subjects With Friedreich's Ataxia

Friedreich Ataxia

United States
Manuela Eicher
Swiss Cancer League; Lindenhofgruppe AG

Completed

Testing of the Cancer Thriving and Surviving Breast Cancer Program (COSS)

Breast Neoplasm | Self-Management | Intervention | Cancer Survivorship | Early-Stage Breast Cancer

Switzerland
The Institute of Molecular and Translational Medicine...

Completed

Clinical Significance of Detecting CEA and CK20 mRNA-positive Cells in Colorectal Cancer Patients

Colorectal Cancer | Circulating Tumor Cell

Czechia
Concert Pharmaceuticals

Completed

Study to Assess the Safety and Pharmacokinetic (PK) of CTP-692 in Healthy Volunteers

Healthy

United States
Pusan National University Yangsan Hospital

Completed

Effect of Oral Collagen Tripeptide on Skin Moisture and Wrinkles in Adult Women

Skin Manifestations | Skin Wrinkling

Korea, Republic of
NYU Langone Health

Completed

Comparison of CTI Ablation Prior to or After LA Ablation for AF

Atrial Fibrillation

United States
Baylor College of Medicine
National Heart, Lung, and Blood Institute (NHLBI); The Methodist Hospital Research... and other collaborators

Completed

Cytotoxic T-Lymphocytes for the Prophylaxis of Cytomegalovirus After Allogeneic Stem Cell Transplant (VICTA)

Cytomegalovirus Infections

United States
GTx

Completed

Study of GTx-024 on Muscle Wasting (Cachexia) Cancer.

Cachexia

United States, Canada
Charles University, Czech Republic

Unknown

AMAZING PRAGUE (PRAGUE-12) (AmP)

Atrial Fibrillation | Restore of Sinus Rhythm | Post-Operative Complications

Czech Republic
Mayo Clinic

Completed

Bortezomib, Cyclophosphamide, and Dexamethasone in Treating Patients With Primary Systemic Light Chain Amyloidosis

Primary Systemic Amyloidosis

United States
Perfusio Corp.
University of Rochester

Not yet recruiting

Clinical Testing Study in Peripheral Arterial Disease (CTS-PAD)

Peripheral Arterial Disease
Henry M. Jackson Foundation for the Advancement...

Recruiting

Digital Therapeutic for Depression After Head Injury in Current and Former US Military Personnel

Depressive Symptoms | Mild Traumatic Brain Injury

United States
Celldex Therapeutics

Completed

A Phase 1 Study of Subcutaneous CDX-0159 in Healthy Subjects

Healthy Subjects

United States
CDx Diagnostics
Rambam Health Care Campus

Withdrawn

CDx Biopsies for Detection of Laryngopharyngeal Reflux and Laryngeal Lesions

Laryngopharyngeal Reflux | Laryngeal Disease | Laryngeal Tumor
Centrexion Therapeutics

Completed

A Study to Evaluate the Safety and Pharmacokinetics of CNTX-6016 in Healthy Subjects

Pain | Chronic Pain | Nociceptive Pain

United States
Cukurova University

Completed

Clinical Evaluation of Injectable Platelet Rich Fibrin With Connective Tissue Graft for the Treatment of Deep Gingival Recession Defects.

Gingival Recession

Turkey
Second Affiliated Hospital, School of Medicine,...
Carbiogene Therapeutics Co. Ltd.

Recruiting

Novel BCMA-targeted CAR-T Cell Therapy for Multiple Myeloma

Relapsed or Refractory Multiple Myeloma

China
Peking Union Medical College Hospital

Recruiting

Different Immunosuppressive Treatment in iMN

Idiopathic Membranous Nephropathy

China
The Affiliated Nanjing Drum Tower Hospital of Nanjing...

Unknown

Neoantigen Reactive T Cells Combined With SHR-1210 for Chinese Patients With Advanced Refractory Solid Tumors (NRT-01)

Advanced Malignant Solid Tumor

China
Kythera Biopharmaceuticals

Completed

Long Term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101

Healthy | Submental Fat

United States, Canada, Australia, United Kingdom
City of Hope Medical Center
National Cancer Institute (NCI)

Active, not recruiting

Intensity-Modulated Radiation Therapy, Etoposide, and Cyclophosphamide Followed By Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia

Leukemia

United States
University of Southern California
National Cancer Institute (NCI)

Terminated

Capecitabine, Cyclophosphamide, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With HER2-Positive Metastatic Breast Cancer

HER2-positive Breast Cancer | Stage IV Breast Cancer | Recurrent Breast Cancer

United States
National Cancer Institute (NCI)

Completed

Tipifarnib and Combination Chemotherapy in Treating Patients With Stage II or Stage III Breast Cancer

Breast Cancer | Male Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer

United States
University of Washington
National Cancer Institute (NCI)

Completed

Cyclophosphamide or Denileukin Diftitox Followed By Expanding a Patient's Own T Cells in the Laboratory in Treating Patients With HER-2/Neu Overexpressing Metastatic Breast Cancer, Ovarian Cancer, or Non-Small Cell Lung Cancer Previously Treated With HER-2/Neu Vaccine

HER2-positive Breast Cancer | Stage IV Breast Cancer | Stage IV Ovarian Epithelial Cancer | Stage IV Ovarian Germ Cell Tumor | Recurrent Breast Cancer | Recurrent Ovarian Epithelial Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Recurrent Ovarian Germ Cell Tumor

United States
Lytix Biopharma AS

Completed

A Phase II Study to Evaluate the Efficacy and Safety of Two Doses of LTX-109 in Impetigo

Non-bullous Impetigo

Dominican Republic
First Hospital of China Medical University

Recruiting

Detection of CTC and ctDNA in the Diagnosis of Metastasis in Gastric Cancer (CTC_ctDNA)

Stomach Neoplasms | Metastasis

China
Lytix Biopharma AS
Herlev Hospital

Completed

LTX-315 and Adoptive T-cell Therapy in Advanced Soft Tissue Sarcoma (ATLAS-IT-04)

Soft Tissue Sarcoma

Denmark
University of Southern California
National Institute on Drug Abuse (NIDA); University of Toronto; RTI International

Completed

Change the Cycle: An RCT to Prevent Injection Initiation (CTC)

Substance Abuse, Intravenous | HIV | Heroin Dependence | Opioid Dependence | Cocaine Dependence | Amphetamine Dependence

United States
Eli Lilly and Company

Completed

A Study of Single and Repeated Doses of LY3556050 in Healthy Participants

Healthy

United States
GTx

Completed

Study to Assess Enobosarm (GTx-024) in Postmenopausal Women With Stress Urinary Incontinence (ASTRID)

Stress Urinary Incontinence

United States
Peking University

Unknown

Liquid Biopsy in Monitoring the Therapeutic Efficacy of Targeted Therapy in Advanced/Metastatic Gastric Cancer

Gastric Cancer

China
Aristotle University Of Thessaloniki
National and Kapodistrian University of Athens; University of Ulm; Greek Alzheimer...

Completed

Combined Cognitive and Physical Exercises Through Computer Games in Elderly: The LLM Project (LLM)

Healthy | Mild Cognitive Impairment | Mild Dementia
Aurolab

Unknown

Natural History of IOL in Pseudo Exfoliation Syndrome (PXF)

Pseudo Exfoliation Syndrome

India
Lytix Biopharma AS
Kael-GemVax Co., Ltd.

Completed

A Study, Combination, Immunologic Study of LTX-315 as Adjunct to GV1001 in Patients Following Curative Surgery for Carcinoma

Carcinoma

Norway
RemeGen Co., Ltd.

Recruiting

To Evaluate the Efficacy and Safety of Disitamab Vedotin Combined With Toripalimab Sequential Chemotherapy as Neoadjuvant Treatment in Patients With HR-positive, HER2-low Breast Cancer

Breast Cancer

China
Vanderbilt-Ingram Cancer Center

Active, not recruiting

Non-Myeloablative Conditioning and Bone Marrow Transplantation

Sickle Cell Disease | Hemoglobinopathies

United States, United Kingdom, France
Washington University School of Medicine

Terminated

Allogeneic or Haploidentical Stem Cell Transplant Followed By High-Dose Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Leukemia, Myeloid, Acute

United States
University Hospital, Montpellier

Completed

Artificial Induction of Labour in Full-term Singleton Pregnancy : Comparative Randomized Trial of Two Strategies (BESTWAY)

Pregnancy Related

France
National Eye Institute (NEI)

Completed

Leflunomide to Treat Uveitis

Uveitis

United States
Columbia University

Unknown

Risk-Adapted Allogeneic Stem Cell Transplantation For Mixed Donor Chimerism In Patients With Non-Malignant Diseases

Severe Combined Immunodeficiency | Fanconi Anemia | Bone Marrow Failure | Osteopetrosis

United States
Roswell Park Cancer Institute

Active, not recruiting

Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant

Hodgkin Lymphoma | Waldenstrom Macroglobulinemia | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome | Plasma Cell Myeloma | Myeloproliferative Neoplasm | Minimal Residual Disease | Graft Versus Host Disease | Severe Aplastic Anemia | Acute Myeloid Leukemia in Remission | Adult Acute Lymphoblastic Leukemia... and other conditions

United States
Roswell Park Cancer Institute
National Cancer Institute (NCI)

Active, not recruiting

Genetically Modified T Cells and Decitabine in Treating Patients With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma

United States
National Cancer Institute (NCI)

Completed

Bevacizumab and Low-Dose Cyclophosphamide in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer

Recurrent Ovarian Carcinoma | Primary Peritoneal Carcinoma | Stage IV Ovarian Cancer

United States
Fudan University

Completed

Anti-EGFR Therapy Plus IMRT Concurrent Chemoradiotherapy in Locally Advanced NPC Resistant to Induction Chemotherapy

Nasopharyngeal Carcinoma

China
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)

Terminated

Chemotherapy Followed by Peripheral Stem Cell Transplantation Plus Biological Therapy in Treating Women With Stage IV Breast Cancer

Breast Cancer

United States

Search clinical trials for: Cyclophosphamide (CTX)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Taiwan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations